The company experienced mixed results in FY25. While Q4 PBT saw significant QoQ growth, overall profitability declined YoY due to falling net sales and EBITDA. A large, exceptional gain boosted FY25 results. Operating cash flow improved.
Tesla Stock Dives as Musk's Politics Spark Fears
Glenmark Gets USFDA Warning
Reliance to Boost India's Solar Capacity
Aurionpro Expands in Europe with AI Lending Solutions
Alvotech & Dr. Reddy's Partner on Keytruda Biosimilar
India's CAD Narrows in Q1 FY26
RBI Cuts Rates, Shifts to Neutral Stance
News that matters the most ⚡